The treatment of stage IIIA Hodgkin's disease: what is the role of combined modality therapy?
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D012008:Recurrence; D012075:Remission, Spontaneous; D013997:Time Factors
D000970:Antineoplastic Agents